Aptorum Group (Aptorum Group) Operating Cash Flow per Share : $-3.12 (TTM As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Aptorum Group Operating Cash Flow per Share?

Aptorum Group's operating cash flow per share for the six months ended in Jun. 2023 was $-1.61. Aptorum Group's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2023 was $-3.12.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 9.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Aptorum Group's Operating Cash Flow per Share or its related term are showing as below:

APM' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -5.2 Med: 2 Max: 9.2
Current: 9.2

During the past 6 years, Aptorum Group's highest 3-Year average Operating Cash Flow per Share Growth Rate was 9.20% per year. The lowest was -5.20% per year. And the median was 2.00% per year.

APM's 3-Year OCF Growth Rate is ranked better than
55.64% of 1242 companies
in the Biotechnology industry
Industry Median: 3.6 vs APM: 9.20

Aptorum Group Operating Cash Flow per Share Historical Data

The historical data trend for Aptorum Group's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptorum Group Operating Cash Flow per Share Chart

Aptorum Group Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Operating Cash Flow per Share

Get a 7-Day Free Trial

-3.60

-4.61

-5.05

-4.18

-3.45

Aptorum Group Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Operating Cash Flow per Share	Get a 7-Day Free Trial							-1.97	-2.21	-1.94	-1.51	-1.61

Competitive Comparison of Aptorum Group's Operating Cash Flow per Share

For the Biotechnology subindustry, Aptorum Group's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aptorum Group's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptorum Group's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Aptorum Group's Price-to-Operating-Cash-Flow falls into.

Aptorum Group Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Aptorum Group's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (A: Dec. 2022 )	=	Cash Flow from Operations (A: Dec. 2022 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2022 )
	=	-12.319	/	3.569
	=	-3.45

Aptorum Group's Operating Cash Flow per Share for the quarter that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (Q: Jun. 2023 )	=	Cash Flow from Operations (Q: Jun. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Jun. 2023 )
	=	-6.193	/	3.850
	=	-1.61

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-3.12

Aptorum Group Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Aptorum Group's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptorum Group (Aptorum Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptorum Group Ltd (NAS:APM) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

17 Hanover Square, London, GBR, W1S 1BN

Website

https://www.aptorumgroup.com

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.